Expression of c-kit and kit-ligand in benign and malignant prostatic tissues

Histology and Histopathology

Volumn 15, Issue 2, 2000, Pages 365-374

  Simak, R ^a   Capodieci, P ^a   Cohen, D W ^a   Fair, W R ^a   Scher, H ^a   Melamed, J ^a   Drobnjak, M ^a   Heston, W D ^a   Stix, U ^b   Steiner, G ^b   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

Benign prostatic hyperplasia; c Kit; Immunohistochemistry; Kit ligand; Prostate neoplasms

Indexed keywords

MONOCLONAL ANTIBODY; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; ENZYME ANALYSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ADENOCARCINOMA; ADULT; ANIMALS; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LIGANDS; MALE; MICE; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL FACTOR; TUMOR CELLS, CULTURED;

EID: 0034001504     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Aaronson S.A. (1991). Growth factors and cancer. Science 254, 1146-1153.
2. Anderson D.M., Lyman S.D., Baird A., Wignall J.M., Eisenman J., Rauch C., March C.J., Boswell H.S., Gimpel S.D., Cosman D. and Williams D.E. (1990). Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms. Cell 63, 235-243.
3. Azizkhan R.G., Azizkhan J.C., Zetter B.R. and Folkman J. (1980). Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J. Exp. Med. 152, 931-944.
4. Beck D., Gross N. and Beretta C. (1993). Expression and functional role of the proto-oncogene c-kit in human neuroblastoma (NBL) cells. Proc. Annu. Meet. Am. Assoc. Cancer. Res. 34A, 307.
5. Berdel W.E., de Vos S., Maurer J., Oberberg D., von Marschall Z., Schroeder J.K., Li J., Ludwig W.D., Kreuser E.D., Thiel E. and Hermann F. (1992). Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit proto-oncogene. Cancer Res. 52, 3498-3502.
6. Brawer M.K., Peehl D.M., Stamey T.A. and Bostwick D.G. (1985). Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res. 45, 3663-3667.
7. v and +/+ mice. J. Natl. Cancer Inst. 74, 671-674.
8. Chromczynski P. and Sacchi N. (1987). Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
9. Copeland N.G., Gilbert D.J., Cho B.C., Donovan P.J., Jenkins N.A., Cosman D., Anderson D., Lyman S.D. and Williams D.E. (1990). Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 63, 175-183.
10. Dabbous M.K., Walker R., Haney L., Carter LM., Nicolson G.L. and Woolley D.E. (1986). Mast cells and matrix degradation at sites of tumour invasion in rat mammary adenocarcinoma. Br. J. Cancer 54, 459-465.
11. DeLellis R.A. (1994). In situ hybridization techniques for the analysis of gene expression: applications in tumor pathology. Hum. Pathol. 25, 580-585.
12. Ehrlich P. (1879). Beitraege zur Kenntniss der granulierten Bindegewebszellen und der eosinophilen Leukocyten. Arch. Anat. Physiol. 166-171.
13. Farram E. and Nelson D.S. (1980). Mouse mast cells as anti-tumor effector cells. Cell Immunol. 55, 294-298.
14. d mutant. Cell 64, 1025-1035.
15. Folkman J., Long D.M. and Becker F.F. (1963). Growth and metastasis of tumor in organ culture. Cancer 16, 453-467.
16. Francke W.W., Schmid E. and Freudenstein C. (1980). Intermediate-sized filaments of the prekeratin type in myoepithelial cells. J. Cell Biol. 84, 633-654.
17. Galli S.J., Iemura A., Garlick D.S., Gamba-Vitalo C., Zsebo K.M. and Andrews R.G. (1993). Reversible expansion of primate mast cell populations in vivo by stem cell factor. J. Clin. Invest. 91, 148-152.
18. Gown A.M. and Vogel A.M. (1984). Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am. J. Pathol. 114, 309-321.
19. Gruber B.L., Schwartz L.B., Ramamurthy N.S., Irani A.M. and Marchese M.J. (1988). Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J. Immunol. 140, 3936-3942.
20. Gruber B.L. and Schwartz L.B. (1990). The mast cell as an effector of connective tissue degradation: a study of matrix susceptibility to human mast cells. Biochem. Biophys. Res. Commun. 171, 1272-1278.
21. Hendrick L. and Epstein J. (1989). Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am. J. Pathol. 13, 389-396.
22. Huang E., Nocka K., Beier D.R., Chu T.Y., Buck J., Lahm H.W., Wellner D., Leder P. and Besmer P. (1990). The hematopoietic growth factor KL is encoded by the SI locus as is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63, 225-233.
23. Huang E.J., Nocka K.H., Buck J. and Besmer P. (1992). Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol. Biol. Cell 3, 349-362.
24. Jacobs S.J. (1983). Spread of prostatic cancer to bone. Urology 21, 337-344.
25. Lammie A., Drobnjak M., Gerald W., Saad A., Cote R. and Cordon-Cardo C. (1994). Expression of c-Kit and Kit ligand proteins in human normal tissues. J. Histochem. Cytochem. 42, 1417-1425.
26. Langley K.E., Bennett L.G., Wypych J., Yancik S.A., Liu X.D., Westcott K.R., Chang D.G., Smith K.A. and Zsebo K.M. (1993). Soluble stem cell factor in human serum. Blood 81, 656-660.
27. Lazard D., Sastre X., Frid M.G., Glukhova M.A., Thiery J.P. and Koteliansky V.E. (1993). Expression of smooth muscle-specific proteins in myoepithelium and stroma myofibroblasts of normal and malignant human breast tissue. Proc. Natl. Acad. Sci. USA 90, 999-1003.
28. Marks R.M., Roche W.R., Czerniecki M., Czerniecki M., Penny R. and Nelson D.S. (1986). Mast cell granules cause proliferation of human microvascular endothelial cells. Lab. Invest. 55, 289-294.
29. Martin F.H., Suggs S.V., Langley K.E., Lu H.S., Ting J., Okino K.H., Morris C.F., McNiece I.K., Jacobsen F.W., Mendiaz E.A., Birkett N.C., Smith K.A., Johnson M.J., Parker V.P., Flores J.C., Patel A.C., Fisher E.F., Erjavec H.O., Herrera C.J., Wypych J., Sachdev R.K., Pope J.A., Leslie I., Wen D., Lin C-H., Cupples R.L. and Zsebo K.M. (1990). Primary structure and functional expression of rat and human stem cell factor DMAs. Cell 63, 203-211.
30. Matsuda R., Takahashi T., Nakamura S., Sekido Y., Nishida K., Seto M., Seito T., Sugiura T., Ariyoshi Y., Takahashi T. and Ueda R. (1993). Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am. J. Pathol. 142, 339-346.
31. Meininger C.J., Yano H., Rottapel R., Bernstein A., Zsebo K.M. and Zetter B.R. (1992). The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79, 958-963.
32. d in equilibrium with +/+ mouse aggregation chimeras. I. Different distribution patterns between melanocytes and mast cells in the skin. Development 102, 107-116.
33. d in equilibrium with +/+ mouse aggregation chimeras. II. Effect of the steel locus on spermatogenesis. Development 102, 117-126.
34. Natali P.G., Nicotra M.R., Sures I., Santoro E., Bigotti A. and Ullrich A. (1992a). Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. Cancer Res. 52, 6139-6143.
35. Natali P.G., Nicotra M., Winkler A.B., Cavaliere R., Bigotti A. and Ullrich A. (1992b). Progression of human cutaneous melanoma is associated with loss of expression of c-kit protooncogene receptor. Int. J. Cancer 52, 197-201.
36. Nocka K., Majumder S., Chabot B., Ray P., Cervone M., Bernstein A. and Besmer P. (1989). Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice-evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 3, 816-826.
37. Sekido Y., Takahashi T., Ueda R., Takahashi M., Suzuki H., Nishida K., Tsukamoto T., Hida T., Shimokata K., Zsebo K.M. and Takahashi T. (1993). Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines expressing the c-kit proto-oncogene. Cancer Res. 53, 1709-1714.
38. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D. and Gabbiani G. (1986). A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 103, 2787-2796.
39. Strohmeyer T., Peter S., Hartmann M., Munemitsu S., Ackermann R., Ullrich A. and Slamon D.J. (1991). Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res. 51, 1811-1816.
40. Tsai M., Shin L.-S., Newlands G.F.J., Takeishi T., Langley K.E., Zsebo K.M., Miller H.R., Geissler E.N. and Galli S.J. (1991). The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype. J. Exp. Med. 174, 125-131.
41. Tsukada T., Tippens D., Gordon D., Ross R. and Gown A.M. (1987). HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. Am. J. Pathol. 126, 51-60.
42. Willis R.E. (1973). Secondary tumors of bone. In: The spread of tumours in the human body. 3rd ed. Butterworth & Co. London, pp 229-250.
43. Williams D.E., Eisenmann J., Baird A., Rauch C., Van Ness K., March C.J., Park L.S., Martin U., Mochizuki D.Y., Boswell H.S., Burgess G.S., Cosman D. and Lyman S.D. (1990). Identification of a ligand for the c-kit proto-oncogene. Cell 63, 167-174.
44. Yarden Y., Kuang W.S. Yang-Feng T., Coussens L., Munemitsu S., Dull T.J., Chen E., Schlessinger J., Francke U. and Ullrich A. (1987). Human protooncogene c-kit, a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J. 6, 3341-3351.
45. Zsebo K.M., Williams D.A., Geissler E.N, Broudy V.C., Martin F.H., Atkins H.L, Hsu R.Y., Birkett N.C., Okino K.H, Murdock D.C., Jacobsen F.W., Langley K.E., Smith K.A., Takeishi T., Cattanach B.M., Galli S.J. and Suggs S.V. (1990). Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63, 213-224.